IDEAYA Biosciences (IDYA) Capital Expenditures Growth (3y) (2021 - 2026)
IDEAYA Biosciences (IDYA) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | - |
| 10 | IDEAYA Biosciences | 3.22 Bn | 2.54 Bn | - | 9.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.03% |
| Dec 31, 2025 | 36.95% |
| Sep 30, 2025 | -36.85% |
| Jun 30, 2025 | 41.66% |
| Mar 31, 2025 | 5.94% |
| Dec 31, 2024 | -30.74% |
| Sep 30, 2024 | -61.69% |
| Jun 30, 2024 | -6.70% |
| Mar 31, 2024 | 51.24% |
| Dec 31, 2023 | 59.63% |
| Sep 30, 2023 | 147.96% |
| Jun 30, 2023 | -38.62% |
| Mar 31, 2023 | 182.75% |
| Dec 31, 2022 | -152.83% |
| Sep 30, 2022 | 209.12% |
| Jun 30, 2022 | 1.61% |
| Mar 31, 2022 | -3.18% |
| Dec 31, 2021 | 40.27% |
| Sep 30, 2021 | -22.94% |